Zhiguo Chen

Zhiguo Chen

Auto-generated profile, based on publicly available information

Zhiguo Chen

Department of Dermatology, University of Virginia School of Medicine, Charlottesville, VA 22903, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CLChung-Ping Liao
Chung-Ping Liao
RBReid C. Booker
Reid C. Booker
JBJean-Philippe Brosseau
Jean-Philippe Brosseau
ZCZhiguo Chen
Zhiguo Chen
JMJuan Mo
Juan Mo
LLLu Q. Le
Lu Q. Le
Neurofibromatosis type 1 associates with multiple neoplasms, and the Schwann cell tumor neurofibroma is the most prevalent. A hallmark feature of neurofibroma is mast cell infiltration, which is recruited by chemoattractant stem cell factor (SCF) and has been suggested to sustain neurofibroma tumorigenesis. In the present study, we use new, genetically engineered Scf mice to decipher the contributions of tumor-derived SCF and mast cells to neurofibroma development. We demonstrate that mast cell infiltration is dependent on SCF from tumor Schwann cells. However, removal of mast cells by depleting the main SCF source only slightly affects neurofibroma progression. Other inflammation signatures show that all neurofibromas are associated with high levels of macrophages regardless of Scf status. These findings suggest an active inflammation in neurofibromas and partly explain why mast cell removal alone is not sufficient to relieve tumor burden in this experimental neurofibroma model. Furthermore, we show that plexiform neurofibromas are highly associated with injury-prone spinal nerves that are close to flexible vertebras. In summary, our study details the role of inflammation in neurofibromagenesis. Our data indicate that prevention of inflammation and possibly also nerve injury at the observed tumor locations are therapeutic approaches for neurofibroma prophylaxis and that such treatment should be explored.

23 April 2014 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
JGJin Gu
Jin Gu
ZCZhiguo Chen
Zhiguo Chen
MLMing Li
Ming Li
TZTiancheng Zhan
Tiancheng Zhan
YYYunfeng Yao
Yunfeng Yao
JGJin Gu
Jin Gu
Given the emerging role of microRNA in tumor disease progression, we investigated the association between microRNA expression, liver metastasis and prognosis of colorectal cancer. Colorectal cancer tissues from patients with or without liver metastases were profiled to identify differentially expressed microRNA. Expression profile was further assessed using quantitative reverse transcription PCR and in situ hybridization. Correlation between miR-181a expression, the most differentially expressed microRNA, between patients with and without liver metastasis, and its downstream target genes were investigated using qRT-PCR. Luciferase reporter assay was conducted to establish functional association between miR-181a and its target genes. Manipulation of miR-181a expression and its consequences in tumor growth and metastasis were demonstrated in various in vitro and in vivo models. miR-181a was revealed being the most elevated in CRC with liver metastases. miR-181a expression correlated with advanced stage, distant metastasis, and served as an independent prognostic factor of poor overall survival. Stable transfection of CRC cell lines with miR-181a promoted cell motility and invasion, as well as tumor growth and liver metastasis,while silencing its expression resulted in reduced migration and invasion. Additionally, we identified WIF-1 as direct and functional targets of miR-181a. Ectopic expression of miR-181a suppressed the epithelial markers E-cadherin and β-catenin, while enhanced the mesenchymal markers vimentin. Our data demonstrate that miR-181a expression is associated with CRC liver metastasis and survival. miR-181a has strong tumor-promoting effects through inhibiting the expression of WIF-1, and its potential role in promoting epithelial-mesenchymal transition.

7 October 2011 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
HHHai‐Bo Han
Hai‐Bo Han
JGJin Gu
Jin Gu
HZHui‐Jing Zuo
Hui‐Jing Zuo
ZCZhi‐Guo Chen
Zhi‐Guo Chen
WZWei Zhao
Wei Zhao
ZZZhiqian Zhang
Zhiqian Zhang

1 November 2014 in Cancer Cell
Verified
Journal Article
Closed access
ZCZhiguo Chen
Zhiguo Chen
CLChiachi Liu
Chiachi Liu
APAmish J. Patel
Amish J. Patel
CLChung-Ping Liao
Chung-Ping Liao
YWYong Wang
Yong Wang
LLLu Q. Le
Lu Q. Le

30 June 2011 in Cancer Research
Verified
Journal Article
Open access
PDF file
LLLu Q. Le
Lu Q. Le
CLChiachi Liu
Chiachi Liu
TSTracey Shipman
Tracey Shipman
ZCZhiguo Chen
Zhiguo Chen
USUeli Suter
Ueli Suter
LPLuis F. Parada
Luis F. Parada
Stem cells are under strict regulation by both intrinsic factors and the microenvironment. There is increasing evidence that many cancers initiate through acquisition of genetic mutations (loss of intrinsic control) in stem cells or their progenitors, followed by alterations of the surrounding microenvironment (loss of extrinsic control). In neurofibromatosis type 1 (NF1), deregulation of Ras signaling results in development of multiple neurofibromas, complex tumors of the peripheral nerves. Neurofibromas arise from the Schwann cell lineage following loss of function at the NF1 locus, which initiates a cascade of interactions with other cell types in the microenvironment and additional cell autonomous modifications. In this study, we sought to identify whether a temporal “window of opportunity” exists during which cells of the Schwann cell lineage can give rise to neurofibromas following loss of NF1. We showed that acute loss of NF1 in both embryonic and adult Schwann cells can lead to neurofibroma formation. However, the embryonic period when Schwann cell precursors and immature Schwann cells are most abundant coincides with enhanced susceptibility to plexiform neurofibroma tumorigenesis. This model has important implications for understanding early cellular events that dictate neurofibroma development, as well as for the development of novel therapies targeting these tumors. Cancer Res; 71(13); 4686–95. ©2011 AACR.

1 January 2019 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
ZCZhiguo Chen
Zhiguo Chen
JMJuan Mo
Juan Mo
JBJean-Philippe Brosseau
Jean-Philippe Brosseau
TSTracey Shipman
Tracey Shipman
YWYong Wang
Yong Wang
LLLu Q. Le
Lu Q. Le
Neurofibromatosis type 1 (NF1) is a cancer predisposition disorder that results from inactivation of the tumor suppressor neurofibromin, a negative regulator of RAS signaling. Patients with NF1 present with a wide range of clinical manifestations, and the tumor with highest prevalence is cutaneous neurofibroma (cNF). Most patients harboring cNF suffer greatly from the burden of those tumors, which have no effective medical treatment. Ironically, none of the numerous NF1 mouse models developed so far recapitulate cNF. Here, we discovered that HOXB7 serves as a lineage marker to trace the developmental origin of cNF neoplastic cells. Ablating Nf1 in the HOXB7 lineage faithfully recapitulates both human cutaneous and plexiform neurofibroma. In addition, we discovered that modulation of the Hippo pathway acts as a “modifier” for neurofibroma tumorigenesis. This mouse model opens the doors for deciphering the evolution of cNF to identify effective therapies, where none exist today. Significance: This study provides insights into the developmental origin of cNF, the most common tumor in NF1, and generates the first mouse model that faithfully recapitulates both human cutaneous and plexiform neurofibroma. The study also demonstrates that the Hippo pathway can modify neurofibromagenesis, suggesting that dampening the Hippo pathway could be an attractive therapeutic target. This article is highlighted in the In This Issue feature, p. 1